Because clinical trials for weight-loss GLP-1 therapy typically excluded people with active infections, healthcare providers must extrapolate from diabetes populations and sound clinical judgment
Mitochondria, oxidative stress, and depression risk: Depression is a huge, global problem
If your study protocol absolutely must avoid raising stress hormoneslike in studies on lean muscle gain, tissue repair, or optimizing post-exercise recoveryIpamorelin is the clear frontrunner
Improvements in weight-related health conditions : Wegovy may help lower blood pressure, cholesterol levels, and blood sugar, reducing the risk of developing or worsening chronic diseases like type 2 diabetes
That timing matters and I will come back to it
Moreno-Borque R, Guhl-Milln G, Mera-Carreiro S, Pazos-Guerra M, Corts-Toro JA, Lpez-Bran E